Short Interest in GMO U.S. Value ETF (NYSEARCA:GMOV) Expands By 47.9%

GMO U.S. Value ETF (NYSEARCA:GMOV) was the target of a large growth in short interest during the month of July. As of July 31st, there was short interest totaling 5,166 shares, a growth of 47.9% from the July 15th total of 3,493 shares. Based on an average daily volume of 11,239 shares, the short-interest ratio is currently 0.5 days. Currently, 0.2% of the shares of the company are short sold.

GMO U.S. Value ETF Stock Up 0.6%

Shares of NYSEARCA GMOV traded up $0.20 during mid-day trading on Tuesday, reaching $32.48. 8,807 shares of the company were exchanged, compared to its average volume of 16,244. The stock has a market capitalization of $103.94 million, a P/E ratio of 12.08 and a beta of 0.62. GMO U.S. Value ETF has a twelve month low of $25.66 and a twelve month high of $32.70. The company’s 50-day simple moving average is $30.89 and its 200-day simple moving average is $29.72.

Hedge Funds Weigh In On GMO U.S. Value ETF

Hedge funds have recently bought and sold shares of the business. Pathway Financial Advisors LLC bought a new position in GMO U.S. Value ETF during the 2nd quarter worth $246,000. Essential Partners LLC boosted its holdings in shares of GMO U.S. Value ETF by 8.6% in the 1st quarter. Essential Partners LLC now owns 60,238 shares of the company’s stock valued at $1,692,000 after purchasing an additional 4,774 shares in the last quarter. Fifth Third Bancorp bought a new position in shares of GMO U.S. Value ETF in the 1st quarter valued at $84,000. Kestra Private Wealth Services LLC acquired a new position in shares of GMO U.S. Value ETF during the 1st quarter worth $333,000. Finally, MML Investors Services LLC acquired a new position in shares of GMO U.S. Value ETF during the 4th quarter worth $1,794,000.

GMO U.S. Value ETF Company Profile

The GMO US Value ETF (GMOV) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, investing primarily in US equity securities. The fund seeks to identify undervalued US stocks using proprietary quantitative methods, capitalizing on perceived market dislocations GMOV was launched on Oct 28, 2024 and is issued by GMO.